Applying Proteomic Technologies to Mouse Models of
Human Cancers

Mouse models of human cancer offer many distinct opportunities to optimize procedures for profiling major human cancers. The NCI Mouse Proteomic Technologies Initiative, a component of NCI's Clinical Proteomic for Cancer initiative, is designed to use these animal models to develop and standardize technologies that help improve the accurate measurement of proteins and peptides linked to cancer processes.

Learn more about the use of mouse models in cancer research, details of the consortia involved, and the resources generated from this program, by clicking on the section links below: